Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Snowflake's aggressive R&D spending is expected to lead to new offerings and robust cross-selling, enhancing its bullish ...

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

John Ransom, Raymond James, joins 'Fast Money' to talk why he is still optimistic on UnitedHealth despite DOJ probe.

Goldman Sachs analyst Will Nance maintained a Buy rating on Visa (V – Research Report) today and set a price target of $384.00. The company’s ...

Lake Street analyst Mark Smith upgraded Kura Sushi (KRUS) to Buy from Hold with a $103 price target Discover the Best Stocks and Maximize Your ...

These four Goldman Sachs dividend energy stock picks offer outstanding entry points and have up to 50% upside potential.

An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all ...

Another ASX 200 blue chip share that could be a top buy for an SMSF is CSL. It is the biotechnology giant behind the CSL ...

Collectively, Wall Street analysts have issued more than 12,000 individual ratings on stocks in the S&P 500. By aggregating ...

In this article, we discuss the 10 best non-tech stocks to buy now for the long term.